0
0 (0%)
Gb Sciences Inc [GBLX]
Source:
Company Overview
GB Sciences, Inc is a plant-inspired, biopharmaceutical research and development company creating patented, disease-targeted formulations of cannabis- and other plant-inspired therapeutic mixtures for the prescription drug market through its wholly owned Canadian subsidiary, GbS Global Biopharma, Inc.
| Country | United States |
| Headquarters | las vegas, nevada |
| Phone Number | (866) 721-0297 |
| Industry | mining |
| CEO | Dr. Andrea Small-Howard |
| Website | www.gbsciences.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0 |
| Operating Profit | $-0.2 |
| Net Income | $-0.2 |
| Net Cash | $-0 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -406.4% |
| Profit as % of Stockholder Equity | 3.3% |
Management Effectiveness
| Return on Equity | 3.3% |
| Return on Assets | -203.2% |
| Turnover Ratio | |
| EBITA | $-0.2 |
Balance Sheet and Cash Flow Measures
| Total Assets | $0.1 |
| Total Liabilities | $5.9 |
| Operating Cash Flow | $-0.1 |
| Investing Cash Flow | $0 |
| Financing Cash Flow | $0.1 |
